3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
95
Head and Neck Neoplasms
92
Nasopharyngeal Carcinoma
35
Nasopharyngeal Neoplasms
15
Laryngeal Neoplasms
12
Oropharyngeal Neoplasms
10
Mouth Neoplasms
10
Hypopharyngeal Neoplasms
9
Colorectal Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Neoplasms
7
Carcinoma, Squamous Cell
7
Neoplasm Metastasis
6
Esophageal Neoplasms
6
Carcinoma
6
Stomach Neoplasms
5
Tongue Neoplasms
4
Recurrence
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Ovarian Neoplasms
4
Laryngeal Diseases
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Sarcoma
3
Salivary Gland Neoplasms
3
Lung Neoplasms
3
Breast Neoplasms
3
Thyroid Neoplasms
2
Pharyngeal Neoplasms
2
Interventions
Radiotherapy, Intensity-Modulated
7
Cisplatin
7
Carboplatin
5
Surveys and Questionnaires
3
Paclitaxel
3
Taxes
2
Radiation
2
Docetaxel
2
Cetuximab
2
Albumin-Bound Paclitaxel
2
utomilumab
1
toripalimab
1
infigratinib
1
fludarabine phosphate
1
fludarabine
1
durvalumab
1
aldesleukin
1
Specimen Handling
1
Radiotherapy
1
Platinum
1
Nimorazole
1
Mass Screening
1
Liquid Biopsy
1
Immunoglobulin G
1
Hydroxyurea
1
Gene Expression Profiling
1
Focus Groups
1
Fluorouracil
1
Drug Therapy
1
Disulfides
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Papillomavirus Infections
×
Fluorouracil
×
Head & Neck
×
Clear all
NCT02258659
2024-09-24
OPTIMA
University of Chicago
Phase 2
Completed
62 enrolled
13 charts